parkinson

Largest-ever Parkinson’s study shows how symptoms differ between men and women

by Lyndsey Collins-Praino, The Conversation edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Parkinson’s disease is the fastest growing neurological disorder, with more than 10 million cases worldwide. Up to 150,000 Australians currently live with the disease and 50 new cases are diagnosed each day. The number of people living […]

Largest-ever Parkinson’s study shows how symptoms differ between men and women Read More »

A first-of-its-kind tool helps Parkinson’s patients decide if deep brain stimulation is right for them

by Julia Milzer, CU Anschutz Medical Campus edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson’s disease. While DBS is one of the most effective interventions for movement symptoms, it’s

A first-of-its-kind tool helps Parkinson’s patients decide if deep brain stimulation is right for them Read More »

Plastic bottles transformed into Parkinson’s drug using bacteria

Peer-Reviewed PublicationUniversity of Edinburgh image: Professor Stephen Wallace harvesting engineered bacteria for analysis. view more  Credit: Edinburgh Innovations A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the

Plastic bottles transformed into Parkinson’s drug using bacteria Read More »

Three-year study tracks early Parkinson’s decline using wearables and patient reports

by Critical Path Institute (C-Path) edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: James Frid from Pexels A new study in the Journal of Neurology offers critical longitudinal insights into how symptoms and functional impacts evolve for individuals with early Parkinson’s disease (PD). Led by Jamie Adams, M.D. and Jennifer

Three-year study tracks early Parkinson’s decline using wearables and patient reports Read More »

How dysfunctional packaging of dopamine advances symptoms of Parkinson’s disease

by Ludwig Maximilian University of Munich edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Deficient uptake of DA into synaptic vesicles of human midbrain neurons results in DA oxidation and α-synuclein pathology. Credit: Science Advances (2026). DOI: 10.1126/sciadv.adz5645 A new study shows how dysfunctional packaging of the neurotransmitter dopamine triggers toxic processes

How dysfunctional packaging of dopamine advances symptoms of Parkinson’s disease Read More »

AI-powered brain models: Sydney-Singapore partnership accelerates breakthroughs in Parkinson’s research

Researchers at the University of Sydney and Duke-NUS Medical School in Singapore are harnessing the power of artificial intelligence and stem cell science to transform our understanding of the human brain and open new doors for treating neurological disorders like Parkinson’s disease. Parkinson’s disease – illustrative photo. Image credit: Pixabay (Free Pixabay license) “My group’s research is focused on

AI-powered brain models: Sydney-Singapore partnership accelerates breakthroughs in Parkinson’s research Read More »

Team pinpoints brain network responsible for Parkinson’s

Share this Article Facebook Twitter Reddit Email You are free to share this article under the Attribution 4.0 International license. Tags brains Parkinson’s disease University Washington University in St. Louis Researchers have identified the brain network responsible for Parkinson’s disease. Parkinson’s disease is a progressive neurological disorder affecting more than 1 million people in the

Team pinpoints brain network responsible for Parkinson’s Read More »

Understanding the path from genetic changes to Parkinson’s disease opens possibilities for early diagnosis

by Baylor College of Medicine edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A team led by researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital has uncovered a chain of events that connects genetic alterations, disruptions

Understanding the path from genetic changes to Parkinson’s disease opens possibilities for early diagnosis Read More »

Stem cell brain implants aim to replace dopamine cells in Parkinson’s trial

by University of Southern California edited by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Parkinson’s disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although available treatments can help manage symptoms, there is currently

Stem cell brain implants aim to replace dopamine cells in Parkinson’s trial Read More »

New stem cell treatment may offer hope for Parkinson’s disease

Keck Medicine of USC investigates a unique therapy that aims to repair damaged brain cells Reports and ProceedingsUniversity of Southern California – Health Sciences image: Brian Lee, MD, PhD, is a neurosurgeon with Keck Medicine of USC and principal investigator of the study. view more  Credit: Ricardo Carrasco III LOS ANGELES — Parkinson’s disease is a progressive neurodegenerative disorder that affects more

New stem cell treatment may offer hope for Parkinson’s disease Read More »

Scroll to Top